St. Petersburg, 22-24 May 2012: 18th Annual Russian Pharmaceutical Forum

Creation Healthcare as the editor of the Healthcare Engagement Strategy e-journal is proud to have been selected as a media partner for the 18th Annual Russian Pharmaceutical Forum, which will take place in St. Petersburg on 22-24 May 2012.

Here is what the organisers of the event are saying…

We are delighted to announce that the 18th Annual RUSSIAN PHARMACEUTICAL FORUM will take place on 22nd – 24th May 2012 inSt. Petersburg,

WHAT TO EXPECT FROM THE RUSSIAN PHARMACEUTICAL FORUM IN 2012:

EVEN MORE HIGH-LEVEL SPEAKERS:

This year’s Forum will bring together more than 90 executive level speakers from the leading companies, plus government officials and industry experts. Early confirmations include:

 

  • Aleksander Filippov, General Director, Rigla Pharmacy Chain
  • Andrey Potapov, Country Head ofRussia, Nycomed: a Takeda Company
  • Anna Yarvits, General Manager,Zentiva,Russia
  • Dmitriy Efimov, General Director, Nizhpharm and Vice President, STADA
  • Igor Filatov, General Director, CV Protek
  • Michael Crow, Vice President & Area Director CIS, GlaxoSmithKline Pharma
  • Milos Petrovic, General Manger, Hoffman laRoche,Russia
    • Naira Adamian Managing Director, Russia & CIS,  Janssen Pharmaceuticals NV
    • Nenad Pavletic, General Manager,AstraZeneca,Russia
    • Odnir Finotti, President, Pró Genéricos (Associação Brasileira das Indústrias de Medicamentos Genéricos), Brasil
    • Patrick Aghanian, Head of Eurasia Region, Sanofi-aventis
    • Sergey Tsyb, Director of the Department of Chemical and Technical Complex and Bioengineering Technologies, Ministry of Industry and Trade ofRussian Federation

and many, many more…

Plus!! DON’T MISS: SPOTLIGHT INTERVIEW with Jostein Davidsen, Head of Emerging Markets, Takeda Company and Area Head of Russia/CIS, Nycomed: a Takeda Company

MORE INTERACTIVE DEBATES at the RUSSIAN PHARMACEUTICAL FORUM

  • CEO PANEL DISCUSSION:  CEOs from the leading pharmaceutical companies will discuss their companies’ need to innovate, adapt to different regulatory measures and operate in a cost-contained environment
  • HEALTHCARE FUNDING DISCUSSION: Development of the healthcare system’s financing mechanism: possible schemes and scenarios
  • TOPICAL DISCUSSION: Positioning for long-term growth:  Generics, biologics, biosimilars, OTC – what will be the key playing fields in pharma over the next 10-15 years?
  • THE BIG HEALTHCARE DEBATE: Ethical issues and drug pricing; role in lobbying; changing public perception of healthcare

 MORE IN-DEPTH SESSIONS AND VALUER-ADDED FEATURES

ALTERNATIVE PARALLEL ONE-DAY EVENT: DAY THREE (24th May) will present you with two different options: Choose between “Achieving Commercial Success in the Pharmaceutical Market” and “Regulatory Affairs and Compliance”

  • SPECIAL FOCUS SESSION: Fuelling sustainable development by effective company & product acquisitions, full exploitation of in-house R&D opportunities and effective in/out-licensing partnerships
  • ANALYTICAL THINK TANK:  A panel of experts will analyse the current  business climate and reform process, and will present a detailed statistical review of the key market segments, therapy areas, products and companies, as well as share their thoughts on the sector’s future development

And much, much more…

Full details about the event are on website https://www.adamsmithconferences.com/hr21chbw

Through truly impartial advice about strategy and implementation, Creation Healthcare helps organisations develop initiatives which are aligned with business goals, and which deliver return on investment.